Acute myeloid leukemia in the elderly: therapeutic options and choice.

about

Acute myeloid leukemia in the elderly: therapeutic options and choice.

Item

http://www.wikidata.org/entity/Q38675781

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Acute myeloid leukemia in the elderly: therapeutic options and choice.

@en

type

Item

label

Acute myeloid leukemia in the elderly: therapeutic options and choice.

@en

prefLabel

Acute myeloid leukemia in the elderly: therapeutic options and choice.

@en

P1476

Acute myeloid leukemia in the elderly: therapeutic options and choice.

@en

P2093

Jonathan A Webster

http://www.w3.org/2001/XMLSchema#string

Keith W Pratz

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials.

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

Age and acute myeloid leukemia.

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

P304

1-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1330956

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28573892

http://www.w3.org/2001/XMLSchema#string